Related Experiment Video
Updated: Mar 4, 2026
06:08
Transcranial Pulse Stimulation for Alzheimer's Patients
Published on: April 4, 2025
2.3K
How does coconut oil affect cognitive performance in alzheimer patients?
José Enrique De la Rubia Ortí1, Carmen Sánchez Álvarez, Pablo Selvi Sabater
1Universidad Católica de Valencia. joseenrique.delarubi@ucv.es.
Nutricion Hospitalaria
|April 20, 2017
Summary
Coconut oil may improve cognitive function in Alzheimer's patients. This study found significant improvements in orientation and language construction after daily coconut oil supplementation.
Area of Science:
- Neuroscience
- Nutritional Science
Background:
- Alzheimer's disease (AD) is a leading cause of dementia with no cure.
- Investigating non-pharmacological strategies like nutritional interventions is crucial.
- Coconut oil is explored as an alternative energy source for neuroprotection in AD.
Purpose of the Study:
- To evaluate the cognitive effects of coconut oil in Alzheimer's patients.
- Specifically assess impacts on orientation, language, memory, and concentration.
- Determine coconut oil's potential as a therapeutic agent for AD.
Main Methods:
- A prospective, longitudinal, clinical trial involving 44 Alzheimer's patients.
- Participants received 40 ml of coconut oil daily for 21 days.
- Cognitive function was assessed using the Mini-Mental State Examination before and after intervention.
Main Results:
- Patients receiving coconut oil showed statistically significant cognitive improvements.
- Improvements were most notable in the orientation and language-construction domains.
- The study highlights varying degrees of cognitive enhancement across different areas.
Conclusions:
- Coconut oil demonstrates potential in enhancing cognitive abilities in Alzheimer's disease.
- The therapeutic effect varies depending on the specific cognitive domain assessed.
- Further research into coconut oil as a complementary therapy for AD is warranted.
More Related Videos
07:42Dual-Task Stroop Paradigm for Detecting Cognitive Deficits in High-Functioning Stroke Patients
Published on: December 16, 2022
3.8K
09:45Motor and Hippocampal Dependent Spatial Learning and Reference Memory Assessment in a Transgenic Rat Model of Alzheimer's Disease with Stroke
Published on: March 22, 2016
10.8K
Related Concept Videos
01:22Alzheimer's Disease: Treatment
1.1K
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
1.1K
01:26Alzheimer's Disease: Overview
1.9K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.9K
01:30Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
751
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
751
01:30Cognitive Development During Adulthood
1.0K
Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
1.0K
01:30Dementia
619
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
619
01:26Atherosclerosis III: Management
529
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
529